546 results on '"Rancati, Tiziana"'
Search Results
2. Optimising inter-patient image registration for image-based data mining in breast radiotherapy
3. Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients
4. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database
5. One-week external beam partial breast irradiation: survival and toxicity outcomes
6. Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
7. Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy
8. Modeling hypoxia-induced radiation resistance and the impact of radiation sources
9. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
10. Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
11. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy
12. Voxel-based analysis: Roadmap for clinical translation
13. Selective sparing of bladder and rectum sub-regions in radiotherapy of prostate cancer combining knowledge-based automatic planning and multicriteria optimization
14. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
15. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients
16. Deep learning-based segmentation of prostatic urethra on computed tomography scans for treatment planning
17. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
18. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
19. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
20. Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
21. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative
22. Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
23. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
24. Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study.
25. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
26. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
27. Reporting Standards for Complication Studies of Radiation Therapy for Pediatric Cancer: Lessons From PENTEC
28. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
29. A Mesoscale Computational Model for Microvascular Oxygen Transfer
30. Breast cancer patient perspective on opportunities and challenges of a genetic test aimed to predict radio-induced side effects before treatment: Analysis of the Italian branch of the REQUITE project
31. The scientific publications of AIFM members in 2015–2019: A survey of the FutuRuS working group
32. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
33. Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study
34. Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review
35. Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.
36. Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects
37. In silico model of the early effects of radiation therapy on the microcirculation and the surrounding tissues
38. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative
39. Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT
40. Knowledge-Based Plan Prediction Modelling of Whole Breast Irradiation: An International Inter-Consortium Experience
41. Optimising Inter-Patient Image Registration for Image-Based Data Mining in Breast Radiotherapy
42. Fat Necrosis after One-Week Partial Breast Irradidation or Standard of Care: A Case-Control Study
43. How do prostate cancer patients navigate the active surveillance journey? A 3-year longitudinal study
44. Impact of kV-cone beam computed tomography dose on DNA repair mechanisms: A pilot study
45. Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer
46. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts
47. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
48. Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations
49. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
50. Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.